NoroMoseley Partners
Status
ACTIVE
Global HQ
Atlanta, United States
Countries of investment
- USA
Investment stages
- Series B
Industries
- Health Tech
- Sales
About
Noro Moseley Partners (NMP) is a distinguished venture capital firm with a strategic emphasis on investing in innovative technology and healthcare companies. Since its inception in 1983, NMP has successfully partnered with over 160 promising startups and early-growth stage businesses, delivering not only capital but also invaluable industry expertise and mentorship. With a commitment to fostering entrepreneurship, NMP leverages its extensive network and resources to help companies scale and achieve their full potential in a dynamic market. The firm's deep understanding of sector trends positions it as a trusted ally for visionary entrepreneurs seeking to drive meaningful impact.
Noro Moseley Partners (NMP) is a distinguished venture capital firm with a strategic emphasis on investing in innovative technology and healthcare companies. Since its inception in 1983, NMP has successfully partnered with over 160 promising startups and early-growth stage businesses, delivering not only capital but also invaluable industry expertise and mentorship. With a commitment to fostering entrepreneurship, NMP leverages its extensive network and resources to help companies scale and achieve their full potential in a dynamic market. The firm's deep understanding of sector trends positions it as a trusted ally for visionary entrepreneurs seeking to drive meaningful impact.
Investment Thesis
Early growth equity for rapidlyscaling B2B software and healthcare companies.
Manager's Experience
Backed by extensive experience in private equity, the fund manager has successfully navigated over 30 investments across technology, healthcare, and consumer sectors. Demonstrating a strategic, operator-first approach, they have effectively collaborated with portfolio companies to drive growth and operational improvements. Their focus on the U.S. and European markets has led to notable exits, including several high-profile sales that yielded significant returns. With a keen eye for early and growth-stage opportunities, they employ a data-driven strategy to identify emerging trends and capitalize on market dynamics.
NoroMoseley Partners Contacts Information
Secondary contact
Team
Mike Charles Moseley
Allen Moseley
William Hudson
Tom Zajac
Karen Debolt
Karen Harford
John Ale
Helen Castleberry
Cliff Kirtland